You are here

  • Home
  • Archive
  • Volume 54, Issue 4
  • Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

Citation Tools

Article menu

This article has a correction. Please see:

Download PDFPDF

Therapeutics
Original Article
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hughes DA, Nicholls K, Shankar SP, et al
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Journal of Medical Genetics 2017;54:288-296.